Yumin Luo Selected Research

Yumin Luo Research Topics

Disease

49	Ischemic Stroke 03/2024 - 05/2011
43	Brain Ischemia (Cerebral Ischemia) 11/2023 - 01/2002
36	Stroke (Strokes) 03/2023 - 06/2004
31	Ischemia 05/2022 - 01/2002
27	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2024 - 06/2004
26	Infarction (Infarctions) 01/2024 - 06/2004
25	Brain Injuries (Brain Injury) 03/2024 - 01/2002
13	Cerebral Infarction 01/2019 - 07/2002
12	Reperfusion Injury 01/2024 - 01/2011
8	Inflammation (Inflammations) 03/2024 - 08/2013
7	Neoplasms (Cancer) 01/2023 - 06/2011
6	Cerebral Hemorrhage 02/2023 - 05/2011
5	Cognitive Dysfunction 06/2023 - 01/2022
5	Hypothermia 06/2018 - 01/2007
4	Moyamoya Disease (Moya-Moya Disease) 10/2023 - 01/2019
4	Brain Edema (Cerebral Edema) 06/2022 - 01/2015
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 03/2009
4	Glioma (Gliomas) 01/2021 - 06/2011
4	Edema (Dropsy) 01/2019 - 05/2015
3	Atherosclerosis 01/2022 - 08/2013
3	Central Nervous System Diseases (CNS Diseases) 10/2021 - 01/2019
3	Hematoma 08/2020 - 12/2012
3	Hyperoxia 10/2015 - 01/2013
2	Neuroinflammatory Diseases 01/2023 - 01/2017
2	Thrombosis (Thrombus) 12/2022 - 11/2007
2	Hemorrhage 05/2022 - 10/2012
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 08/2013
2	Necrosis 01/2021 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
2	Brain Infarction 01/2021 - 01/2016
2	Hyperglycemia 02/2020 - 05/2009
2	Hypertension (High Blood Pressure) 04/2018 - 03/2009
2	Hypoxia (Hypoxemia) 01/2017 - 01/2013
2	Astrocytoma (Pilocytic Astrocytoma) 05/2016 - 06/2011
2	Transient Ischemic Attack 05/2009 - 05/2002
2	Hypotension (Low Blood Pressure) 05/2009 - 03/2009
2	Seizures (Absence Seizure) 07/2006 - 02/2006

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2002
21	Neuroprotective AgentsIBA 06/2023 - 07/2002
12	MicroRNAs (MicroRNA)IBA 01/2023 - 06/2013
11	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2012
11	Erythropoietin FDA Link 04/2023 - 05/2009
10	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 05/2009
9	Oxygen (Dioxygen)IBA 03/2024 - 05/2011
9	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2023 - 05/2015
6	AntioxidantsIBA 01/2022 - 06/2004
6	Long Noncoding RNAIBA 01/2022 - 01/2017
6	Messenger RNA (mRNA)IBA 01/2019 - 08/2008
5	CytokinesIBA 05/2022 - 04/2006
5	ZincIBA 01/2022 - 04/2014
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2002
5	Small Interfering RNA (siRNA)IBA 01/2017 - 06/2011
4	ChloridesIBA 11/2023 - 05/2009
4	AntagomirsIBA 01/2023 - 08/2015
4	Circular RNAIBA 01/2023 - 01/2019
4	Interleukin-10 (Interleukin 10)IBA 05/2022 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 08/2014
4	CaspasesIBA 04/2013 - 05/2002
4	Caspase 3 (Caspase-3)IBA 02/2006 - 05/2002
3	3-n-butylphthalide (butylphthalide)IBA 11/2023 - 01/2022
3	triphenyltetrazoliumIBA 01/2019 - 06/2013
3	chrysophanic acidIBA 09/2018 - 09/2016
3	Chelating AgentsIBA 01/2018 - 10/2015
3	Evans Blue (Blue, Evans)FDA Link 11/2016 - 06/2011
3	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 11/2016 - 04/2014
3	Cytochromes c (Cytochrome c)IBA 10/2015 - 06/2005
2	EnzymesIBA 03/2024 - 01/2007
2	Indicators and Reagents (Reagents)IBA 08/2023 - 04/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2021
2	Interleukin-2 (IL2)IBA 05/2022 - 08/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2017
2	BerberineIBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2021 - 04/2006
2	Phosphotransferases (Kinase)IBA 01/2020 - 10/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2015
2	Glial Fibrillary Acidic ProteinIBA 12/2019 - 01/2018
2	Histones (Histone)IBA 12/2019 - 05/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2018 - 08/2014
2	Malondialdehyde (Propanedial)IBA 02/2015 - 08/2014
2	Protein Kinases (Protein Kinase)IBA 10/2014 - 08/2014
2	Superoxide DismutaseIBA 10/2014 - 08/2014
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2014 - 04/2013
2	NAD (NADH)IBA 04/2013 - 01/2007
2	JNK Mitogen-Activated Protein KinasesIBA 06/2012 - 06/2005
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2012 - 03/2009
2	pyrazolanthroneIBA 06/2012 - 06/2005
2	Eosine Yellowish-(YS) (Eosin)IBA 06/2011 - 08/2008
2	Hematoxylin (Haematoxylon)IBA 06/2011 - 08/2008
2	Serine (L-Serine)FDA Link 01/2007 - 06/2005
2	Kainic Acid (Kainate)IBA 07/2006 - 02/2006
2	tat Gene Products (tat Protein)IBA 02/2006 - 07/2002
2	Caspase 9IBA 06/2005 - 05/2002

Therapy/Procedure

14	Therapeutics 02/2024 - 05/2009
5	Ischemic Postconditioning 01/2018 - 06/2011
3	Thrombectomy 12/2023 - 02/2020
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2009
3	Intra-Arterial Infusions 01/2016 - 06/2011
2	Induced Hypothermia 10/2015 - 05/2009
2	Intraperitoneal Injections 02/2006 - 07/2002